Ozono, S., Tsukamoto, T., Naito, S., Horie, S., Ohashi, Y., Uemura, H., . . . Akaza, H. (2018). Efficacy and safety of 3‐month dosing regimen of degarelix in Japanese subjects with prostate cancer: A phase III study. Cancer Sci.
Citação norma ChicagoOzono, Seiichiro, et al. "Efficacy and Safety of 3‐month Dosing Regimen of Degarelix in Japanese Subjects With Prostate Cancer: A Phase III Study." Cancer Sci 2018.
Citação norma MLAOzono, Seiichiro, et al. "Efficacy and Safety of 3‐month Dosing Regimen of Degarelix in Japanese Subjects With Prostate Cancer: A Phase III Study." Cancer Sci 2018.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.